April 11, 2011

A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

November 14, 2010

The world of generic drugs has a big year ahead of it. Actually, it has...

July 19, 2009

“We’re already paying for it—it’s just hidden in your premiums.”...